If You Invested $1000 In This Stock 15 Years Ago, You Would Have $13,000 Today
Welltower (NYSE:WELL) has outperformed the market over the past 15 years by 6.41% on an annualized basis producing an average annual return of 19.04%. Currently, Welltower has a market capitalization
Unveiling 11 Analyst Insights On American Healthcares
American Healthcares (NYSE:AHR) underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.The table below offers a condensed view of their recen
American Healthcares Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/16/2024 11.27% JMP Securities → $16 Reiterates Market Outperform → Market Outperform 04/03/2024 11.27%
Medical Properties Trust, Arbor Realty Trust in Real Estate Losers
Scotiabank Maintains Sector Perform on Ventas, Raises Price Target to $51
Scotiabank analyst Nicholas Yulico maintains Ventas (NYSE:VTR) with a Sector Perform and raises the price target from $47 to $51.
Ventas Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/16/2024 4.7% Scotiabank $47 → $51 Maintains Sector Perform 03/18/2024 2.65% Evercore ISI Group → $50 Up
Cracking The Code: Understanding Analyst Reviews For Healthpeak Properties
Analysts' ratings for Healthpeak Properties (NYSE:DOC) over the last quarter vary from bullish to bearish, as provided by 7 analysts.The table below provides a snapshot of their recent ratings, showca
Healthcare Realty Trust Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/16/2024 -1.42% Scotiabank $15 → $16 Maintains Sector Perform 05/08/2024 -1.42% Wedbush $15 → $16 Mainta
Welltower Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/16/2024 5.59% Scotiabank $96 → $108 Maintains Sector Outperform 05/08/2024 2.66% Mizuho $98 → $105 Main
Healthpeak Properties Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/16/2024 3.09% JP Morgan $19 → $21 Maintains Neutral 05/03/2024 — Wedbush Upgrades Neutral → Outperform
Unpacking the Latest Options Trading Trends in Welltower
Investors with significant funds have taken a bearish position in Welltower (NYSE:WELL), a development that retail traders should be aware of.This was brought to our attention today through our monito
REITs Cut Capital Raising Activities by More Than Half in April, Says Report
Medical Properties Trust, Office Properties Income in Real Estate Losers
Shares of 'Meme Stocks' Are Trading Lower Amid Continued Volatility Following a Surge in Retail Investor Interest.
Shares of 'Meme Stocks' Are Trading Lower Amid Continued Volatility Following a Surge in Retail Investor Interest.
Sabra Health Care REIT Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/15/2024 1.9% Scotiabank $14 → $15 Maintains Sector Perform 01/30/2024 42.66% Deutsche Bank → $21 Initia
Top 3 Real Estate Stocks That May Implode In Q2
As of May 15, 2024, three stocks in the real estate sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.The RSI is a momentum indicator
Six U.S. REITs Hiked Their Dividend Payouts in April - S&P Global Market Intelligence
This Is What Whales Are Betting On Medical Properties Trust
Whales with a lot of money to spend have taken a noticeably bearish stance on Medical Properties Trust.Looking at options history for Medical Properties Trust (NYSE:MPW) we detected 13 trades.If we co
Shares of 'Meme Stocks' and High-short Interest Stocks Are Trading Higher Amid a Renewed Surge in the Space After Popular Retail Trader 'Roaring Kitty' Returned to Social Media.
Shares of 'Meme Stocks' and High-short Interest Stocks Are Trading Higher Amid a Renewed Surge in the Space After Popular Retail Trader 'Roaring Kitty' Returned to Social Media.
Medical Properties Trust Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/14/2024 -13.79% RBC Capital → $5 Downgrades Outperform → Sector Perform 04/17/2024 -13.79% Deutsche Ban